Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Qili Pharmaceutical is a modernized pharmaceutical manufacturer based in Chengdu, China, specializing in patent traditional Chinese medicines (TCM) and western chemical medicines. Founded in 1992, the company operates advanced GMP-certified manufacturing lines for large-volume injections, small-volume injections, powder injections, tablets, capsules, syrups, and oral liquids. Its product portfolio covers therapeutic areas such as anti-infectives, pain management, cardiovascular and cerebrovascular diseases, respiratory disorders, and digestive health, with notable products including Diyu Shengbai Capsules and various antibiotic injections. In 2012, the company was acquired by Hengkang Medical Group, further integrating its manufacturing and commercialization capabilities within a larger healthcare conglomerate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Qili Pharmaceutical.